The present invention relates to compounds of Formula (I),
or a form thereof, wherein ring A, R
1
, L and R
2
are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.
N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES
申请人:Salvati Mark E.
公开号:US20100041717A1
公开(公告)日:2010-02-18
Compounds of formula (Ia) and (Ib), wherein A, B, C, R
1
and R
14
are described herein.
式(Ia)和(Ib)的化合物,其中A、B、C、R1和R14如本文所述。
Compounds for and methods of treating diseases
申请人:Alterity Therapeutics Limited
公开号:US11155547B1
公开(公告)日:2021-10-26
The present invention provides heterocyclic compounds of formula (I) that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to compounds that modulate iron and to compounds for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA).